Rhabdomyolysis and creatine kinase elevation;Rhabdomyolyse und erhöhung der kreatinkinase

Zeitschrift fur Rheumatologie

Volumn 72, Issue 3, 2013, Pages 236-241

  Lehmann, P ^a   Hartung, W ^a   Fleck, M ^a,b  

^a Asklepios Klinikum Bad Abbach   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Creatine kinase; Energy metabolism; Myopathy; Organ damage; Rhabdomyolysis

Indexed keywords

CREATINE KINASE;

ARTICLE; CELL METABOLISM; CREATINE KINASE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG TOXICITY; ENDOCRINE DISEASE; ENERGY METABOLISM; GENETIC DISORDER; HUMAN; METABOLIC DISORDER; MUSCLE INJURY; MYOSITIS; RHABDOMYOLYSIS; RHEUMATIC DISEASE; SKELETAL MUSCLE;

BIOLOGICAL MARKERS; CREATINE KINASE; HUMANS; RHABDOMYOLYSIS;

EID: 84885293516     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-012-1081-x     Document Type: Article

References (14)

1. Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80(3):1107-1213 (Pubitemid 30452013)
2. Löffler G, Petrides P (1997) Biochemie und Pathobiochemie Aufl. Springer, Berlin Heidelberg New York
3. Schlattner U, Tokarska-Schlattner M, Wallimann T (2006) Mitochondrial creatine kinase in human health and disease. Biochimic Biophys Acta 1762(2):164-180 (Pubitemid 43006023)
4. Warren JD, Blumbergs PC, Thompson PD (2002) Rhabdomyolysis: a review. Muscle Nerve 25(3):332-347 (Pubitemid 34203210)
5. Huerta-Aladin AL, Varon J, Marik PE (2005) Bench to bedside review: rhabdomyolysis-an overview for clinicians. Crit Care 9(2):158-169
6. Sathasivam S (2012) Statin induced myotoxicity. Eur J Intern Med 23(4):317-324
7. Owczarek J, Jasi?ska M, Orszulak-Michalak D (2005) Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep 57(1):23-34 (Pubitemid 40601538)
8. Druey KM, Greipp PR (2010) Narrative review: the systemic capillary leak syndrome. Ann Intern Med 153(2):90-98
9. Hohenegger M (2012) Drug induced rhabdomyolysis. Curr Opin Pharmacol 12(3):335-339
10. Müller-Felber W, Schoser B, Pongratz D et al (2006) Idiopathische CK-Erhöhung. Nervenheilkunde 25(7):577-578
11. Writing Committee, Pasternak RC, Smith SC et al (2002) ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Stroke 33(9):2337-2341 (Pubitemid 35014654)
12. Boutaud O, Roberts LJ II (2011) Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure. Free Radic Biol Med 51(5):1062-1067
13. Al-Ismaili Z, Piccioni M, Zappitelli M (2011) Rhabdomyolysis: pathogenesis of renal injury and management. Pediatr Nephrol 26(10):1781-1788
14. Fachinformation Mannitol, Stand März 2011